CAS RN: 26723-60-4
3-Chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-ol 5,5-dioxide
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250831
250mg / 1g / 5g / 25g / 100g
Confirm by inquiry
Shanghai 8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 26723-60-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
25g
≥95%
0
Out of Stock
Shenzhen
Inquiry
26723-60-4 / 3-chloro-6-methyl-5,5-dioxo-11H-benzo[c][2,1]benzothiazepin-11-ol
Standard CAS: 26723-60-4
Multi CAS: No
Basic Information
copy
CAS
26723-60-4 copy
Multi CAS
No copy
Molecular Formula
C14H12ClNO3S copy
Molecular Weight
309.800000 copy
Exact Mass
309.022642 copy
SMILES
CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)O copy
InChI
InChI=1S/C14H12ClNO3S/c1-16-12-5-3-2-4-10(12)14(17)11-7-6-9(15)8-13(11)20(16,18)19/h2-8,14,17H,1H3 copy
InChIKey
KBRSJPHSCOAFDR-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
20 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.14 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
77.54 copy
TPSA
57.61 copy
LogP / Solubility
WLOGP
2.56 copy
MLOGP
2.27 copy
XLogP3
2.1 copy
Consensus LogP
2.31 copy
Log S (ESOL)
-3.82 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.95 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.8 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.79 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2 copy